Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
195.70M | 271.01M | 416.83M | 1.59B | 2.14B | 310.40M | Gross Profit |
64.66M | 44.98M | 58.09M | 57.50M | 117.51M | 64.30M | EBIT |
-101.10M | -119.12M | -358.02M | -51.05M | 13.11M | -25.87M | EBITDA |
-75.29M | -114.39M | -354.07M | -525.84M | 23.23M | -68.02M | Net Income Common Stockholders |
-99.51M | -117.42M | -352.85M | -269.99M | 2.98M | -73.72M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
117.25M | 35.32M | 38.29M | 55.71M | 191.74M | 361.54M | Total Assets |
996.41M | 755.03M | 1.00B | 1.53B | 3.10B | 4.19B | Total Debt |
167.40M | 166.82M | 189.94M | 177.85M | 223.94M | 377.06M | Net Debt |
50.14M | 131.51M | 152.94M | 123.77M | 74.72M | 111.56M | Total Liabilities |
418.47M | 612.89M | 738.45M | 875.87M | 2.20B | 3.35B | Stockholders Equity |
507.92M | 142.14M | 265.32M | 652.54M | 898.57M | 841.86M |
Cash Flow | Free Cash Flow | ||||
13.57M | 39.25M | -35.17M | -16.86M | 27.34M | -52.90M | Operating Cash Flow |
14.35M | 40.12M | -34.72M | -15.94M | 29.80M | -49.58M | Investing Cash Flow |
32.90M | 2.15M | 12.86M | -30.57M | 8.80M | -165.48M | Financing Cash Flow |
-47.17M | -42.98M | 5.55M | -51.03M | -168.65M | 417.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $58.10B | 5.92 | 14.62% | 6.94% | 1.21% | 2.15% | |
65 Neutral | HK$15.09B | 15.57 | 19.23% | 1.91% | 12.91% | 5.31% | |
64 Neutral | $4.44B | 11.99 | 5.16% | 249.23% | 4.01% | -11.87% | |
58 Neutral | HK$96.20M | 12.33 | 5.22% | 4.05% | 1.74% | -46.43% | |
58 Neutral | $24.48B | 14.29 | 4.39% | 4.83% | 18.63% | -50.14% | |
45 Neutral | €10.24B | ― | -26.60% | ― | -46.56% | -1256.77% | |
36 Underperform | HK$98.25M | ― | ― | -56.43% | 57.64% |